Table 1.
Characterization of the WSPs detected in genomes of SARS-CoV-2.
| Segment ID | Segment positiona (begin–end) | WSPsb | nt mutation (# isolates) | Position in the codon | #codon | Amino acid |
|---|---|---|---|---|---|---|
| S2 | 2899–3179 | nsp3-[3,037] | U (184)/C (409) | Third | 106 | Phenylalanine/Phenylalanine |
| S4 | 8639–8919 | nsp4-[8,782] | U (183)/C (410) | Third | 76 | Serine/Serine |
| S6 | 10,959–11,219 | nsp6-[11,083] | C (1)/U (99)/G (493) | Third | 37 | Phenylalanine/Phenylalanine/Leucine |
| S8 | 14,259–14,539 | nsp12-[14,408] | U (184)/C (409) | Second | 323 | Leucine/Proline |
| S10 | 17,600–18,200 | nsp13-[17,747] | U (101)/C (492) | Second | 504 | Leucine/Proline |
| nsp13-[17,858] | G (101)/A (492) | Second | 541 | Cysteine/Tyrosine | ||
| nsp14-[18,060] | U (105)/C (488) | Third | 7 | Leucine/Leucine | ||
| S12 | 23,270–23,550 | S-[23,403] | G (185)/A (408) | Second | 614 | Glycine/Aspartate |
| S14 | 28,004–28,285 | ORF8-[28,144] | C (184)/U (409) | Second | 84 | Serine/Leucine |
| S16 | 28,745–29,025 | N-[28,881] | A (60)/G (533) | Second | 203 | Lysine/Arginine |
| N-[28,882] | A (60)/G (533) | Third | ||||
| N-[28,883] | C (60)/G (533) | First | 204 | Glycine/Arginine |
aRelative to the multiple sequence alignment constructed for full-length genomes.
bWidely shared polymorphism (WSP) positions are relative to the reference genome (GISAID accession ID: EPI_ISL_402124).